BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 750274)

  • 1. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
    Nishikawa H; Yasaki S; Yoshimoto T; Sakatani M; Itoh M; Masuno T; Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
    Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
    Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of human lung cancer with BCG cell-wall skeleton.
    Yasumoto K; Manabe H; Ueno M; Ohta M; Ueda H
    Gan; 1976 Dec; 67(6):787-95. PubMed ID: 798710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
    Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
    Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
    Yamamura Y; Sakatani M; Ogura T; Azuma I
    Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
    Robinson E; Haim N; Segal R; Veseley Z; Mekori T
    Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
    Morishita M
    Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic alterations and active aspecific immunotherapy in lung cancer patients.
    Banna P; Murabito R; Saggio A; Cordopatri F; Riggi M; Campo ME; Cinà C; Latteri S
    Ital J Surg Sci; 1983; 13(2):133-7. PubMed ID: 6195126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune status in lung cancer: effects of BCG immunotherapy.
    Gross NJ; Eddie-Quartey AC
    Am Rev Respir Dis; 1976 Apr; 113(4):457-64. PubMed ID: 178255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
    Ogura T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
    Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
    Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of advanced primary lung cancer, particularly immunotherapy with BCG-CWS (author's transl)].
    Ohta M; Iida A; Ueda H; Yasumoto K; Manabe H
    Kyobu Geka; 1977 Jul; 30(7):581-5. PubMed ID: 904107
    [No Abstract]   [Full Text] [Related]  

  • 15. A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia.
    Ohino R; Ueda R; Imai Kato Y; Watanabe E; Morishima Y; Yokomaku S; Kobayashi M; Takeyama H; Ezaki K; Kawashima K; Hirano M; Ohara K; Kosaki T; Yoshikawa S; Yamada K
    Gan; 1978 Apr; 69(2):179-86. PubMed ID: 355038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
    Warren SE; Crispen RG; Nika B
    Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of immunotherapy in the combined treatment of lung cancer].
    Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
    Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunologic capacity of cancer patients and BCG-CSW immunotherapy].
    Yasumoto K; Manabe H; Yanagawa E; Nagano S; Ueda H
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):449-51. PubMed ID: 381535
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
    Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
    Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer immunotherapy with BCG cell-wall skeleton (author's transl)].
    Azuma I; Yamamura Y
    Tanpakushitsu Kakusan Koso; 1978 May; 23(6):625-40. PubMed ID: 211546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.